IMAX Co. (NYSE:IMAX – Get Free Report) insider Kenneth Ian Weissman sold 6,309 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $25.51, for a total transaction of $160,942.59. Following the completion of the transaction, the insider now directly owns 25,139 shares in the company, valued at $641,295.89. This represents a 20.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
IMAX Trading Up 1.1 %
NYSE IMAX opened at $25.84 on Wednesday. The firm’s fifty day simple moving average is $23.16 and its two-hundred day simple moving average is $20.28. The firm has a market capitalization of $1.36 billion, a P/E ratio of 58.73, a P/E/G ratio of 1.68 and a beta of 1.23. IMAX Co. has a 12-month low of $13.20 and a 12-month high of $26.84.
IMAX (NYSE:IMAX – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.12. IMAX had a return on equity of 7.53% and a net margin of 6.74%. The firm had revenue of $91.50 million for the quarter, compared to the consensus estimate of $93.71 million. During the same period in the previous year, the business earned $0.27 EPS. The firm’s revenue for the quarter was down 11.9% on a year-over-year basis. As a group, sell-side analysts predict that IMAX Co. will post 0.77 earnings per share for the current fiscal year.
Hedge Funds Weigh In On IMAX
Analyst Ratings Changes
A number of equities research analysts have weighed in on IMAX shares. Roth Mkm lifted their target price on IMAX from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Thursday, October 31st. StockNews.com downgraded IMAX from a “buy” rating to a “hold” rating in a report on Tuesday. Wedbush reissued an “outperform” rating on shares of IMAX in a research report on Wednesday, November 27th. Rosenblatt Securities restated a “buy” rating and issued a $28.00 price target on shares of IMAX in a report on Thursday, October 31st. Finally, Barrington Research reiterated an “outperform” rating and set a $24.00 price objective on shares of IMAX in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.22.
Check Out Our Latest Report on IMAX
About IMAX
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Featured Stories
- Five stocks we like better than IMAX
- Stock Market Sectors: What Are They and How Many Are There?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Trading Halts Explained
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Best Stocks Under $10.00
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.